Erika Carmel-Tech (XTAE:ERKA) Other Stockholders Equity: ₪4.73 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:ERKA Erika Carmel-Tech Ltd XTAE:ERKA
36 GF Score
Price ₪0.49
GF Value ₪0.55
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Erika Carmel-Tech Other Stockholders Equity?

Erika Carmel-Tech XTAE:ERKA -1.42% 36 Other Stockholders Equity is ₪4.73 Mil as of Dec. 2025. GuruFocus rates XTAE:ERKA with a GF Score™ of 36/100 and a GF Value™ of ₪0.55 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Erika Carmel-Tech's Other Stockholders Equity for the quarter that ended in Dec. 2025 was ₪4.73 Mil.

Erika Carmel-Tech's quarterly Other Stockholders Equity declined from Dec. 2024 (₪4.78 Mil) to Jun. 2025 (₪4.72 Mil) but then increased from Jun. 2025 (₪4.72 Mil) to Dec. 2025 (₪4.73 Mil).

Erika Carmel-Tech's annual Other Stockholders Equity increased from Dec. 2023 (₪4.06 Mil) to Dec. 2024 (₪4.78 Mil) but then declined from Dec. 2024 (₪4.78 Mil) to Dec. 2025 (₪4.73 Mil).

Erika Carmel-Tech Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Erika Carmel-Tech's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Erika Carmel-Tech Other Stockholders Equity Chart

Erika Carmel-Tech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 6.58 3.85 4.06 4.78 4.73

Erika Carmel-Tech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.06 4.28 4.78 4.72 4.73
XTAE:ERKA
36GF Score
Erika Carmel-Tech Ltd XTAE:ERKA
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Erika Carmel-Tech Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₪4.73 Mil mean?
Erika Carmel-Tech (XTAE:ERKA) has a Other Stockholders Equity of ₪4.73 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Erika Carmel-Tech and its competitors.
Is Erika Carmel-Tech's Other Stockholders Equity too high?
Erika Carmel-Tech's current Other Stockholders Equity is ₪4.73 Mil. Overall, Erika Carmel-Tech has a GF Score™ of 36/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Erika Carmel-Tech's Other Stockholders Equity compare to ABT and SYK?
Erika Carmel-Tech's Other Stockholders Equity of ₪4.73 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Erika Carmel-Tech and its competitors. Erika Carmel-Tech's current Other Stockholders Equity is ₪4.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Erika Carmel-Tech stock overvalued right now?
Based on GuruFocus' analysis, Erika Carmel-Tech (XTAE:ERKA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₪0.55, compared to a current price of ₪0.49 — trading 11.5% below its estimated fair value. The current Other Stockholders Equity is ₪4.73 Mil. Erika Carmel-Tech's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Erika Carmel-Tech (XTAE:ERKA), the current Other Stockholders Equity is ₪4.73 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Erika Carmel-Tech (XTAE:ERKA) Overvalued in 2026?

Based on GuruFocus' analysis, Erika Carmel-Tech stock appears to be undervalued. The current stock price of ₪0.49 is trading 11.5% below its estimated GF Value™ of ₪0.55. GuruFocus considers Erika Carmel-Tech to be Modestly Undervalued.

Key valuation signals for XTAE:ERKA:

  • Other Stockholders Equity: ₪4.73 Mil
  • GF Value™: ₪0.55 vs. price of ₪0.49 (11.5% below fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the XTAE:ERKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Erika Carmel-Tech Business Description

Address Nahum Hat 5, Entrance 2, Haifa, ISR, 3508504
Erika Carmel-Tech Ltd Formerly Erika B-Cure Laser Ltd is engaged in the development and production of laser devices for the treatment of pain and wounds. Its devices provide treatment for Knee Pain, Lower Back Pain, Neck Pain, Shoulder Pain, Finger Joint pain, and Burns.
36GF Score

Get the complete analysis for XTAE:ERKA

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.49
Price
₪0.55
GF Value